Status:
UNKNOWN
Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Hemorrhage
Shock
Eligibility:
All Genders
Brief Summary
The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines
Eligibility Criteria
Inclusion
- Indication for NovoSeven treatment according to our guideline
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
End Date :
December 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00192933
Start Date
January 1 2000
End Date
December 1 2010
Last Update
October 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark, DK-2100